{"title":"多功能RuO2致敏Co3O4核壳声酶异质结用于声动力和纳米催化Co扩增免疫治疗","authors":"Guijun Zou, Nan Wang, Rui Ma, Bijiang Geng, Bing Ma, Chaojun Zhang","doi":"10.1002/smll.202507712","DOIUrl":null,"url":null,"abstract":"It is believed that reactive oxygen species (ROS)‐mediated immunogenic cell death (ICD) can promote DC maturation and initiate cytotoxic T lymphocytes infiltration, but the limited ROS generation and immunosuppressive tumor microenvironments (TME) restrict the effectiveness of sonodynamic and nanocatalytic therapy (SDT/NCT). Herein, RuO<jats:sub>2</jats:sub> shell is utilized as the auxiliary sonosensitizers and nanozymes to sensitize Co<jats:sub>3</jats:sub>O<jats:sub>4</jats:sub> core for the construction of core‐shell Co<jats:sub>3</jats:sub>O<jats:sub>4</jats:sub>@RuO<jats:sub>2</jats:sub> heterojunction sonozymes. Enhanced sonodynamic and multienzyme‐mimic activities are observed in the heterojunction sonozymes, thanks to improved electron‐hole separation kinetics. Co<jats:sub>3</jats:sub>O<jats:sub>4</jats:sub>@RuO<jats:sub>2</jats:sub>‐triggered cascade amplification of antitumor immune response is realized by the heterojunction construction, GSH depletion, and relief of hypoxia co‐augmented ROS yield, which significantly induced a robust ICD effect. Significant antitumor effects have been observed to eliminate primary tumors and stop the growth of distant tumors through Co<jats:sub>3</jats:sub>O<jats:sub>4</jats:sub>@RuO<jats:sub>2</jats:sub>‐mediated SDT and NCT co‐amplified immunotherapy. This study provides promising insights into the development of heterojunction sonozymes as a novel antitumor nanoplatform to induce durable and potent immune responses.","PeriodicalId":228,"journal":{"name":"Small","volume":"11 1","pages":""},"PeriodicalIF":12.1000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Multifunctional RuO2 Sensitized Co3O4 Core‐Shell Sonozyme Heterojunctions for Sonodynamic and Nanocatalytic Co‐Amplified Immunotherapy\",\"authors\":\"Guijun Zou, Nan Wang, Rui Ma, Bijiang Geng, Bing Ma, Chaojun Zhang\",\"doi\":\"10.1002/smll.202507712\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"It is believed that reactive oxygen species (ROS)‐mediated immunogenic cell death (ICD) can promote DC maturation and initiate cytotoxic T lymphocytes infiltration, but the limited ROS generation and immunosuppressive tumor microenvironments (TME) restrict the effectiveness of sonodynamic and nanocatalytic therapy (SDT/NCT). Herein, RuO<jats:sub>2</jats:sub> shell is utilized as the auxiliary sonosensitizers and nanozymes to sensitize Co<jats:sub>3</jats:sub>O<jats:sub>4</jats:sub> core for the construction of core‐shell Co<jats:sub>3</jats:sub>O<jats:sub>4</jats:sub>@RuO<jats:sub>2</jats:sub> heterojunction sonozymes. Enhanced sonodynamic and multienzyme‐mimic activities are observed in the heterojunction sonozymes, thanks to improved electron‐hole separation kinetics. Co<jats:sub>3</jats:sub>O<jats:sub>4</jats:sub>@RuO<jats:sub>2</jats:sub>‐triggered cascade amplification of antitumor immune response is realized by the heterojunction construction, GSH depletion, and relief of hypoxia co‐augmented ROS yield, which significantly induced a robust ICD effect. Significant antitumor effects have been observed to eliminate primary tumors and stop the growth of distant tumors through Co<jats:sub>3</jats:sub>O<jats:sub>4</jats:sub>@RuO<jats:sub>2</jats:sub>‐mediated SDT and NCT co‐amplified immunotherapy. This study provides promising insights into the development of heterojunction sonozymes as a novel antitumor nanoplatform to induce durable and potent immune responses.\",\"PeriodicalId\":228,\"journal\":{\"name\":\"Small\",\"volume\":\"11 1\",\"pages\":\"\"},\"PeriodicalIF\":12.1000,\"publicationDate\":\"2025-10-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Small\",\"FirstCategoryId\":\"88\",\"ListUrlMain\":\"https://doi.org/10.1002/smll.202507712\",\"RegionNum\":2,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Small","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1002/smll.202507712","RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Multifunctional RuO2 Sensitized Co3O4 Core‐Shell Sonozyme Heterojunctions for Sonodynamic and Nanocatalytic Co‐Amplified Immunotherapy
It is believed that reactive oxygen species (ROS)‐mediated immunogenic cell death (ICD) can promote DC maturation and initiate cytotoxic T lymphocytes infiltration, but the limited ROS generation and immunosuppressive tumor microenvironments (TME) restrict the effectiveness of sonodynamic and nanocatalytic therapy (SDT/NCT). Herein, RuO2 shell is utilized as the auxiliary sonosensitizers and nanozymes to sensitize Co3O4 core for the construction of core‐shell Co3O4@RuO2 heterojunction sonozymes. Enhanced sonodynamic and multienzyme‐mimic activities are observed in the heterojunction sonozymes, thanks to improved electron‐hole separation kinetics. Co3O4@RuO2‐triggered cascade amplification of antitumor immune response is realized by the heterojunction construction, GSH depletion, and relief of hypoxia co‐augmented ROS yield, which significantly induced a robust ICD effect. Significant antitumor effects have been observed to eliminate primary tumors and stop the growth of distant tumors through Co3O4@RuO2‐mediated SDT and NCT co‐amplified immunotherapy. This study provides promising insights into the development of heterojunction sonozymes as a novel antitumor nanoplatform to induce durable and potent immune responses.
期刊介绍:
Small serves as an exceptional platform for both experimental and theoretical studies in fundamental and applied interdisciplinary research at the nano- and microscale. The journal offers a compelling mix of peer-reviewed Research Articles, Reviews, Perspectives, and Comments.
With a remarkable 2022 Journal Impact Factor of 13.3 (Journal Citation Reports from Clarivate Analytics, 2023), Small remains among the top multidisciplinary journals, covering a wide range of topics at the interface of materials science, chemistry, physics, engineering, medicine, and biology.
Small's readership includes biochemists, biologists, biomedical scientists, chemists, engineers, information technologists, materials scientists, physicists, and theoreticians alike.